FI791565A - Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar - Google Patents

Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar

Info

Publication number
FI791565A
FI791565A FI791565A FI791565A FI791565A FI 791565 A FI791565 A FI 791565A FI 791565 A FI791565 A FI 791565A FI 791565 A FI791565 A FI 791565A FI 791565 A FI791565 A FI 791565A
Authority
FI
Finland
Prior art keywords
prostaglandinfoereningar
innalollande
pharmaceutical composition
formulations
prostacyclin
Prior art date
Application number
FI791565A
Other languages
English (en)
Other versions
FI68359B (fi
FI68359C (fi
Inventor
Ian Seymour Watts
Peter Hugh Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI791565A publication Critical patent/FI791565A/fi
Publication of FI68359B publication Critical patent/FI68359B/fi
Application granted granted Critical
Publication of FI68359C publication Critical patent/FI68359C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI791565A 1978-05-17 1979-05-16 Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning FI68359C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17
GB2017578 1978-05-17

Publications (3)

Publication Number Publication Date
FI791565A true FI791565A (fi) 1979-11-18
FI68359B FI68359B (fi) 1985-05-31
FI68359C FI68359C (fi) 1985-09-10

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791565A FI68359C (fi) 1978-05-17 1979-05-16 Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning

Country Status (28)

Country Link
US (1) US4335139A (fi)
EP (1) EP0005768B1 (fi)
JP (1) JPS54163809A (fi)
KR (1) KR830000527B1 (fi)
AT (2) AT365926B (fi)
AU (1) AU525695B2 (fi)
BE (1) BE876296A (fi)
CA (1) CA1141661A (fi)
CH (1) CH641044A5 (fi)
CS (1) CS214798B2 (fi)
DE (2) DE2966046D1 (fi)
DK (1) DK156004C (fi)
ES (1) ES480597A1 (fi)
FI (1) FI68359C (fi)
FR (1) FR2425856A1 (fi)
GR (1) GR68452B (fi)
HU (1) HU182746B (fi)
IL (1) IL57298A (fi)
IT (1) IT1116840B (fi)
LU (1) LU81272A1 (fi)
MC (1) MC1265A1 (fi)
NL (1) NL7903871A (fi)
NZ (1) NZ190462A (fi)
PH (1) PH15850A (fi)
PL (1) PL134004B1 (fi)
SE (1) SE450930B (fi)
SU (1) SU978715A3 (fi)
ZA (1) ZA787353B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
HU207220B (en) * 1988-06-17 1993-03-29 Wellcome Found Process for producing pharmaceutical composition for diminishing enhanced pressure of the pulmonary circulation
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
ATE424399T1 (de) * 2005-06-29 2009-03-15 Verisfield Uk Ltd Pharmazeutische zusammensetzungen von risperidon in wässriger lösung
US8318802B2 (en) * 2006-02-03 2012-11-27 Actelion Pharmaceuticals Ltd. Epoprostenol formulation and method of making thereof
CA2698721A1 (en) * 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
JPS542335A (en) * 1977-05-20 1979-01-09 Wellcome Found Medical composition

Also Published As

Publication number Publication date
FI68359B (fi) 1985-05-31
IT7949064A0 (it) 1979-05-16
FR2425856A1 (fr) 1979-12-14
PL134004B1 (en) 1985-07-31
DK201879A (da) 1979-11-18
ATE4411T1 (de) 1983-08-15
CH641044A5 (de) 1984-02-15
DE2920020C2 (fi) 1988-09-01
DE2920020A1 (de) 1979-11-29
HU182746B (en) 1984-03-28
US4335139A (en) 1982-06-15
IT1116840B (it) 1986-02-10
EP0005768A1 (en) 1979-12-12
DE2966046D1 (en) 1983-09-15
GR68452B (fi) 1981-12-30
SE450930B (sv) 1987-08-17
AU525695B2 (en) 1982-11-25
FR2425856B1 (fi) 1982-06-25
ATA363479A (de) 1981-07-15
EP0005768B1 (en) 1983-08-10
DK156004C (da) 1989-11-06
NZ190462A (en) 1982-05-31
FI68359C (fi) 1985-09-10
LU81272A1 (fr) 1979-12-07
SU978715A3 (ru) 1982-11-30
JPS6358810B2 (fi) 1988-11-17
DK156004B (da) 1989-06-12
AU4704279A (en) 1979-11-22
NL7903871A (nl) 1979-11-20
CA1141661A (en) 1983-02-22
MC1265A1 (fr) 1980-03-28
PL215627A1 (fi) 1981-08-07
ZA787353B (en) 1980-08-27
JPS54163809A (en) 1979-12-26
ES480597A1 (es) 1980-08-16
IL57298A (en) 1983-09-30
SE7904284L (sv) 1979-11-18
IL57298A0 (en) 1979-09-30
PH15850A (en) 1983-04-13
KR830000527B1 (ko) 1983-03-12
AT365926B (de) 1982-02-25
BE876296A (fr) 1979-11-16
CS214798B2 (en) 1982-05-28

Similar Documents

Publication Publication Date Title
SE8700498D0 (sv) Novel pharmaceologically active compounds
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DK173883D0 (da) Substituerede 8-phenylxanthiner
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
FI791565A (fi) Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar
NO791205L (no) 2-(2-tenoyltio)-propionylglycin, fremgangsmaate for fremstilling derav og farmasoeytiske formuleringer som inneholder forbindelsen
ES551886A0 (es) Procedimiento para la obtencion de s.s -dioxido de 3-acetilamino-4-metoxi-benzoisotiazol
IT1069522B (it) Procedimento per la preparazione di butandiolo e..o butendiolo
EG14440A (en) Preparation of an optically active benzamide the optically active benzamide so obtained and pharmaceutical compositions containing it
ES2019634B3 (es) Terapia con clorfeniramina.
FI821324A0 (fi) Oxazolderivat
SE8503447D0 (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
AU560165B2 (en) Chromophoric peptides
IT7920415A0 (it) Preparazione di ceruletide. procedimento per la
IE790954L (en) Pharmaceutical formulations containing prostaglandin¹compounds
IT1061264B (it) Procedimento per la preparazione di 3.3.4.4..tetraclorotetraidrotiofene..1.1..diossido
IT7921319A0 (it) Procedimento per la preparazione di clorozocitina e relative formulazioni farmaceutiche.
NO911988D0 (no) Stabiliserte vandige formuleringer av smaa peptider.
IT7823273A0 (it) Procedimento per la preparazione di ciclacillina anidra.

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: THE WELLCOME FOUNDATION LIMITED